Caribou Biosciences (CRBU) Non Operating Income (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Non Operating Income data on file, last reported at $1.2 million in Q1 2026.

• On a quarterly basis, Non Operating Income fell 59.1% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was -$2.1 million, a 113.15% decrease from a year earlier, with the FY2025 full-year figure at -$331000.0, down 101.89% from the prior year.
• Non Operating Income for Q1 2026 stood at $1.2 million, down from $1.4 million in the prior quarter.
• Over the last five years, Non Operating Income for CRBU reached as high as $5.8 million in Q2 2024 and fell as low as -$6.5 million in Q2 2025.
• Historically, Non Operating Income has averaged $2.3 million across 5 years, with a median of $3.1 million in 2023.
• Across the five-year window, Non Operating Income surged 10931.25% in 2022 and sank 212.34% in 2025, its largest moves.
• Year by year, Non Operating Income stood at $3.7 million in 2022, then declined by 14.46% to $3.1 million in 2023, then gained by 7.86% to $3.4 million in 2024, then tumbled by 58.09% to $1.4 million in 2025, then dropped by 15.55% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $1.2 million in Q1 2026, $1.4 million in Q4 2025, and $1.9 million in Q3 2025.